A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

NCT00548925 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathic Pain

Interventions

DRUG: ABT-894
DRUG: placebo

Sponsor

AbbVie (prior sponsor, Abbott)